Dr Reddy’s Sells North American Rights For Celecoxib Oral Solution
As Company Partners With BioDelivery Sciences For Elyxyb
Executive Summary
India’s Dr Reddy’s has sold the US and Canadian rights to its 25mg/ml Elyxyb (celecoxib) oral solution to US-based BioDelivery Sciences International, for an upfront payment of $6m, followed by $9m within one year from closing the deal.